Background and Mission

Background

The National Cancer Center (NCC) has established the Center for Cancer Genomics and Advanced Therapeutics (C-CAT）in June 2018. This is in response to the final report issued on June 27^th, 2017, by Expert Meeting for Cancer Genomic Medicine Promotion Consortium, appointed by the Ministry of Health, Labour and Welfare. The Meeting called for a new agency to construct and operate a “Repository of cancer genomics information”, a master database for cancer genomic medicine and research in Japan.

Mission of C-CAT

1. Control quality and advance genomic diagnosis of cancer
   

   • Accumulate clinical and genomic information of Japanese cancer patients and establish a database optimized to serve the populace

   • Provide support to Expert Panels at Designated Core Hospitals for Cancer Genomic Medicine

   • Deliver engaging messages to the public, and advocate policy underpinned by nation-wide statistics of cancer genomic medicine

2. Lead information sharing：
   

   • Promote data sharing among designated and cooperative hospitals of cancer genomic medicine following appropriate protocol, and promote cancer care covered by national healthcare insurance

3. Promote clinical trials, research and development：
   

   • Establish data utilization as foundation for clinical trials including investigator-initiated trials, and for drug/device development and precision medicine for cancer patients

4. Conduct research, and nurture talent in preparation for the introduction of Whole Genome Sequencing to national health care